Literature DB >> 1379989

Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies.

P A Trinel1, C Faille, P M Jacquinot, J C Cailliez, D Poulain.   

Abstract

Six monoclonal antibodies (MAbs) from various laboratory sources (EB-CA1, EB-CA2, H5, AF1, C6, and 5B2), reacting with the polysaccharidic moieties of Candida albicans mannoproteins, were used for epitope mapping by an enzyme-linked immunosorbent assay (ELISA) with neoglycolipids and by Western blotting (immunoblotting) of a C. albicans germ tube extract. The ELISA involved neoglycolipids constructed from three families of oligomannosides released by sequential depolymerization of C. albicans phosphopeptidomannan by acid hydrolysis (NGLH), beta-elimination (NGLO), and acetolysis (NGLA). All of the MAbs exhibited low reactivities against NGLO. MAbs EB-CA1, EB-CA2, and H5 reacted mainly against NGLA, and MAbs C6 and AF1 recognized mainly NGLH, whereas MAb 5B2 reacted with both families of neoantigens. When this method was compared with Western blotting, strong reactivity to NGLA was associated with the presence of epitopes shared by high-molecular-weight mannoproteins, whereas strong reactivity to NGLH was associated with a reactivity to a family of 14- to 18-kDa antigens. The reactivity of MAb 5B2 was associated with both high-molecular-weight mannoproteins and the 14- to 18-kDa antigens. In relation to the present knowledge about the structure of the C. albicans phosphopeptidomannan oligomannosidic repertoire, these results provide preliminary data concerning the molecular basis of the recognition of mannopyranosyl sequences by MAbs and their distribution among C. albicans mannoproteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379989      PMCID: PMC257398          DOI: 10.1128/iai.60.9.3845-3851.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Caveats in the investigation of form-specific molecules of Candida albicans.

Authors:  D L Brawner; J E Cutler; W L Beatty
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

2.  Secretion of glycoproteins through the cell wall of Candida albicans.

Authors:  D Poulain; J C Cailliez; J F Dubremetz
Journal:  Eur J Cell Biol       Date:  1989-10       Impact factor: 4.492

3.  Candida albicans C3d receptor, isolated by using a monoclonal antibody.

Authors:  L Linehan; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species.

Authors:  A Cassone; A Torosantucci; M Boccanera; G Pellegrini; C Palma; F Malavasi
Journal:  J Med Microbiol       Date:  1988-12       Impact factor: 2.472

5.  Two nuclear mutations that block mitochondrial protein import in yeast.

Authors:  M P Yaffe; G Schatz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro.

Authors:  R P Podzorski; G R Gray; R D Nelson
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

7.  Structural study of cell wall phosphomannan of Candida albicans NIH B-792 (serotype B) strain, with special reference to 1H and 13C NMR analyses of acid-labile oligomannosyl residues.

Authors:  H Kobayashi; N Shibata; M Nakada; S Chaki; K Mizugami; Y Ohkubo; S Suzuki
Journal:  Arch Biochem Biophys       Date:  1990-04       Impact factor: 4.013

8.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids.

Authors:  M P Hayette; G Strecker; C Faille; D Dive; D Camus; D W Mackenzie; D Poulain
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Preparation of monoclonal antibodies reactive with beta-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain.

Authors:  M Tojo; N Shibata; M Kobayashi; T Mikami; M Suzuki; S Suzuki
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

View more
  34 in total

1.  Beta-1,2-mannosylation of Candida albicans mannoproteins and glycolipids differs with growth temperature and serotype.

Authors:  P A Trinel; T Jouault; J E Cutler; D Poulain
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

Authors:  T Jouault; C Fradin; P A Trinel; D Poulain
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Re-expression by Candida albicans germ tubes of antigens lost during subculture of blastospores.

Authors:  F L Hernando; E Calvo; J A Rodriguez; P L Barea; A Rementeria; M J Sevilla; J Ponton
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

5.  Cross-reactivity of the PLATELIA CANDIDA antigen detection enzyme immunoassay with fungal antigen extracts.

Authors:  Dagmar Rimek; Jagpal Singh; Reinhard Kappe
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  The Cek1‑mediated MAP kinase pathway regulates exposure of α‑1,2 and β‑1,2‑mannosides in the cell wall of Candida albicans modulating immune recognition.

Authors:  E Román; I Correia; A Salazin; C Fradin; T Jouault; D Poulain; F-T Liu; J Pla
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

7.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides.

Authors:  P A Trinel; M Borg-von-Zepelin; G Lepage; T Jouault; D Mackenzie; D Poulain
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant.

Authors:  W L Chaffin; B Collins; J N Marx; G T Cole; K J Morrow
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis.

Authors:  B Sendid; M Tabouret; J L Poirot; D Mathieu; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.